Drug Research Immune Response Virus 
Drug Target Review
OCTOBER 26, 2023
1 Adeno-associated virus (AAV) vectors are the leading platform for in vivo gene delivery for the treatment of various human diseases. 9 In addition, host immune responses further add to the complexity of developing cell-specific AAV capsids for clinical applications. Nature reviews Drug discovery 18 , 358-378 (2019).
NIH Director's Blog: Drug Development
FEBRUARY 16, 2021
ACTIV was founded last April to accelerate drug research that typically requires more than a decade of clinical ups and downs to develop a safe, effective therapy. They are called immune modulators because they help to minimize the effects of an overactive immune response in some COVID-19 patients.
Expert insights. Personalized for you.
105 
Let's personalize your content